INVESTINGFrance's Sanofi to Buy Cancer-Drug Specialist Synthorx for $68-Share, or $2.5 BillionBy Tony OwusuDec 9, 2019 10:53 AM EST
INVESTINGMerck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 BillionBy Martin BaccardaxDec 9, 2019 9:47 AM EST
STOCKSPfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema DrugBy Martin BaccardaxSep 27, 2019 9:50 AM EDT
MARKETSFDA Says Sanofi's Zantac Medication Has Impurity That Could Cause CancerBy Brenda BouwSep 13, 2019 1:01 PM EDT
MARKETSUniQure Jumps on Report It's Exploring a Possible SaleBy Joseph WoelfelJun 17, 2019 9:33 AM EDT
STOCKSElon Musk Has Lost It and Must Consider Bringing In Facebook's Sheryl SandbergBy Brian SozziAug 17, 2018 9:04 AM EDT
POLITICSDrug Pricing Turns to Insulin As Politicians, AMA And Docs Look to PharmaBy Bill MeagherJun 22, 2018 8:02 PM EDT
MARKETSEli Lilly's Trulicity benefits from growth of diabetes drugsBy Armie Margaret LeeMay 23, 2018 1:39 PM EDT
POLITICSTrump administration rolls out shaming as drug pricing toolBy Bill MeagherMay 16, 2018 3:02 PM EDT
MERGERS AND ACQUISITIONSAceto's search for deal may be slowed by DOJ subpoenaBy Bill MeagherApr 25, 2018 6:25 PM EDT
STOCKSPhilippine FDA Says Sanofi of Knew of Vaccine's Dangers in 2015By Tony OwusuFeb 26, 2018 3:07 PM EST
HEALTHKey measure for generic drug access left out of federal budgetBy Bill MeagherFeb 9, 2018 5:34 PM EST
MERGERS AND ACQUISITIONSStock Market Drop Not Seen Dampening Healthcare Deal ActivityBy Armie Margaret LeeFeb 8, 2018 6:48 PM EST
STOCKSSanofi announces second billion-dollar deal in a week, and it may not be doneBy Armie Margaret LeeJan 29, 2018 1:59 PM EST
FUTURES5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know Before the Market OpensBy Joseph WoelfelJan 29, 2018 7:42 AM EST
OPINIONImmunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMIBy Michael BrownJan 22, 2018 7:23 PM EST
HEALTHQuanterix Uses JPMorgan Healthcare Conference To Scout Sales CandidatesBy Bill MeagherJan 22, 2018 4:52 PM EST
MARKETSDow, S&P 500 and Nasdaq Hit New Records as Senate Reaches Deal to End ShutdownBy Joseph WoelfelJan 22, 2018 4:12 PM EST
MARKETSDow, S&P 500 and Nasdaq Shake Off Government Shutdown to Trade HigherBy Joseph WoelfelJan 22, 2018 10:17 AM EST
VIDEOA Government Shutdown Won't Crush Stock Market, a New England Patriots Win WillBy Brian SozziJan 22, 2018 8:48 AM EST
STOCKSWill the Government Shutdown Kill the Mind-Blowing Bull Market?By Brian SozziJan 22, 2018 8:04 AM EST
VIDEOGovernment Shutdown and Everything Else You Need to Know Monday MorningBy Daniel KuhnJan 22, 2018 7:21 AM EST
FUTURESShutdown Enters Day 3, Sanofi Buys Bioverativ - 5 Things You Must Know Before the Market OpensBy Joseph WoelfelJan 22, 2018 6:53 AM EST
